Sabinsa
About
Company description
Sabinsa Group of Companies manufacture and market standardized herbal extracts, phytonutrients and many specialty fine chemicals which find important applications in the areas of Nutritional, Cosmeceutical, Pharmaceutical and Food applications.
Quick facts
Sales markets | Eastern Europe; Western Europe |
---|---|
Affiliated categories: | Botanical Extracts |Nutrients More |
Recently at
Vitafoods Europe 2024
14 - 16 May 2024 - Geneva, Switzerland We were at stand A90 See our Exhibitor Profile See full Exhibitor ListFi Europe
28 - 30 Nov 2023 Frankfurt, Germany We were at stand 3.0G20 See our Exhibitor Profile See full Exhibitor ListVitafoods Europe Online and In-Person
1 - 12 May 2023 - Online We were at stand B80 See our Exhibitor Profile See full Exhibitor ListNews about Sabinsa
23 Nov 2022
Discover how Sabinsa’s curcuminoid innovation C3 Reduct® can deliver health and formulation benefits
Sabinsa has developed Curcumin C3 Reduct®, the only reductive metabolites of curcuminoids on the market to have been approved as a Novel Food by the European Food Safety Authority (EFSA). Easy to integrate into existing production processes and with the concentrated benefits of curcumin, C3 Reduct® has been shown to boost organ health and deliver a range of other targeted functionalities.
Read more3 Feb 2020
How credible are weight management ingredients?
Weight management is one of the most in-demand areas for functional ingredients – but some compounds are more promising than others.
Read more27 Jan 2020
Spotlight on the health halo of green tea
Green tea has gained an enormous amount of attention for its high antioxidant content, and new studies continue to back multiple benefits for the beverage and its extracts – despite uncertainty over how these benefits are delivered.
Read more24 Jun 2019
Could new research heat up the turmeric market?
Sales of turmeric – and the curcumin extracted from it – have soared over the past few years, and new research suggesting it could help relieve pain from knee osteoarthritis looks set to boost the ingredient even further.
Read more